Hone Health reports that low testosterone levels in men are linked to increased heart disease risk, making monitoring testosterone vital for heart health.

GoodRx reports that GLP-1 medications, while not FDA-approved for high blood pressure, can aid in lowering it through weight loss and heart health benefits.

Polycystic ovary syndrome is an inaccurate name for a condition that affects millions of people worldwide. Its new name can help address missed diagnoses and fragmented care.

Doctronic reports that Foundayo, an oral GLP-1 for diabetes, shows promise but lacks long-term safety data beyond 68 weeks; ongoing studies are needed.

Ivím Health reports that Ozempic can disrupt women's hormones during weight loss, leading to worsening symptoms like hot flashes and sleep issues.

LMNT reports that electrolytes are crucial for women's hormone balance, supporting cell communication and overall well-being throughout the menstrual cycle.

GoodRx reports that Foundayo, a new oral weight-loss pill, is FDA-approved for obesity treatment, offering an alternative to injections with effective results.

Hone Health reports 9 common misconceptions about hormone replacement therapy (HRT) that may hinder women's health decisions.

Alma reports on perimenopause symptoms for women over 35, emphasizing fluctuating hormones, mood changes, and the need for comprehensive care.

Hone Health reports that no test can confirm perimenopause; however, blood tests are crucial for ruling out similar conditions and guiding treatment.